Cancer Research
-
Pietenpol to receive American Society of Clinical Oncology’s highest honor
Jennifer Pietenpol, Ingram Professor of Cancer Research and professor of biochemistry, is the 2024 recipient of the Science of Oncology Award, which is presented annually to an individual who has made outstanding contributions to basic or translational research in cancer. Read MoreApr 17, 2024
-
VICC funding opportunity: Waddell Walker Hancock Cancer Discovery Fund Award; apply by Oct. 9
The A.B. Hancock Jr. Memorial Laboratory for Cancer Research in collaboration with the Vanderbilt-Ingram Cancer Center announced a funding opportunity to support a cancer-related project and investigator. The award provides $50,000 to any stage, tenure-track investigator to pursue a high-impact research project. The chosen investigator will also be named a Hancock Scholar Read MoreSep 21, 2023
-
Foundation funds research to block drug resistance in cancer treatment
The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a three-year grant to support research led by Houra Merrikh, PhD, professor of Biochemistry, and Ben Ho Park, MD, PhD, the Benjamin F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, to create an anti-evolution drug to reduce the capacity of cancer cells to develop resistance. Read MoreSep 5, 2023
-
Biomedical engineering graduate student is a Ford Foundation Fellow
Biomedical engineering graduate student Ismael Ortiz has been awarded a fellowship in the Ford Foundation Fellowship Programs competition administered at the Fellowships Office of the National Academies of Sciences, Engineering and Medicine. Ford Predoctoral Fellowships are highly competitive with a typical overall success rate of only 4% to 5%. Fellowships provide three years of support at... Read MoreFeb 7, 2023
-
Lee named 2022 Innovation Fund investigator by The Pew Charitable Trusts
Ethan Lee, professor of cell and developmental biology and pharmacology, has been named a 2022 Innovation Fund investigator by The Pew Charitable Trusts. Read MoreSep 27, 2022
-
Nanoengineering may hold the key to developing more effective, safer treatments for a deadly childhood cancer
Neuroblastoma is one of the most common—and lethal—forms of childhood cancer, accounting for 15 percent of pediatric cancer deaths each year. (Despite the name, neuroblastoma is not a form of brain cancer; it typically consists of tumors found in the abdomen, chest, neck, pelvis and bones.) Currently, children with neuroblastoma are treated with aggressive forms... Read MoreSep 15, 2022
-
Nanoengineering may hold the key to developing more effective, safer treatments for a deadly childhood cancer
Neuroblastoma is one of the most common—and lethal—forms of childhood cancer, accounting for 15 percent of pediatric cancer deaths each year. (Despite the name, neuroblastoma is not a form of brain cancer; it typically consists of tumors found in the abdomen, chest, neck, pelvis and bones.) Currently, children with neuroblastoma are treated with aggressive forms... Read MoreSep 15, 2022
-
Engineering professor to use $3M grant to develop technology to help cancer patients better fight disease
Associate Professor of Chemical and Biomolecular Engineering John Wilson has received a $3 million grant from the National Cancer Institute to develop technology that seeks to boost a person’s immune system to better fight cancer. Read MoreSep 6, 2022
-
Three Vanderbilt biomedical researchers named 2022 Pew Scholars
Mariana Byndloss, assistant professor of pathology, microbiology and immunology, and William Wan, assistant professor of biochemistry, have been named 2022 Pew Scholars in the Biomedical Sciences. The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust have selected Alexander Bick, assistant professor of genetic medicine, to join the 2022 class of Pew-Stewart Scholars for Cancer Research. Read MoreJun 14, 2022
-
Research Snapshot: Collaborative research lays groundwork for potential treatment of a rare and deadly type of cancer
A collaborative project between William Tansey and Stephen Fesik has laid the foundation for pre-clinical and clinical trials for rare childhood tumors that are diagnosed in 25 children per year in the United States. Read MoreApr 22, 2022
-
Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy
A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors. Read MoreJan 14, 2022
-
Professor makes Vanderbilt-discovered cancer targeting molecule freely available to researchers through collaboration with Boehringer Ingelheim
Stephen Fesik’s discovery of a cancer-targeting molecule has been made freely accessible through opnMe for global researchers to advance research into cancer therapeutics. Read MoreNov 15, 2021
-
$1.9 million NIH project to investigate effects of shear stress on cancer cells
A biomedical engineering professor has received a $1.9 million NIH grant to investigate the effects of mechanical stimuli such as shear stress on the behavior of cancer cells in blood flow. J. Lawrence Wilson Professor Mike King and his research group will develop the devices for the study as well as new cell lines to... Read MoreSep 9, 2021
-
$1.9 million NIH project to investigate effects of shear stress on cancer cells
A biomedical engineering professor has received a $1.9 million NIH grant to investigate the effects of mechanical stimuli such as shear stress on the behavior of cancer cells in blood flow. J. Lawrence Wilson Professor Mike King and his research group will develop the devices for the study as well as new cell lines to... Read MoreSep 9, 2021
-
Interdisciplinary melanoma research brings understanding of cellular resistance to cancer treatment, opening doors to new cures
Drug-tolerant persister cells–those that survive cancer treatment–found to rely on similar survival mechanisms across cancers, in a groundbreaking study led by Vanderbilt researchers. Read MoreOct 21, 2020
-
Vanderbilt bioengineer’s trailblazing cancer research receives $1M W. M. Keck Foundation grant
A bold engineering approach by a Vanderbilt University researcher to sort breast cancer cells based on their behavior first has produced compelling data that show less migratory cells create more metastases, contradicting the prevailing hypothesis on how cancer spreads. Read MoreJul 14, 2020
-
Breast cancer vaccine research delivers promising results
Vanderbilt researchers have developed what appears to be a simple and promising treatment for breast cancer metastasis. Read MoreJun 11, 2020
-
Potential new cancer target
Vanderbilt researchers have discovered the involvement of a certain type of adenosine receptor in mediating signaling that supports tumor growth and metastasis. Read MoreJun 4, 2020
-
Multinational consortium reports COVID-19 impact on cancer patients
People with cancer sickened by COVID-19 have a crude death rate of 13%, according to the largest series of data released thus far from a multinational perspective. The data on more than 900 patients also revealed cancer-specific factors associated with increased mortality. Read MoreJun 3, 2020
-
Potential prostate cancer biomarkers
An analysis of more than 140,000 people of European ancestry has identified blood protein biomarkers associated with prostate cancer risk. Read MoreSep 19, 2019